Status epilepticus in the elderly: Epidemiology, clinical aspects and treatment

Neurology International

Volumn 4, Issue 3, 2012, Pages 78-84

  de Assis, Telma M R ^a,b   Costa, Gersonita ^a   Bacellar, Aroldo ^a   Orsini, Marco ^b   Nascimento, Osvaldo J M ^b  

^a Sao Rafael Hospital   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Case fatality; Elderly; Epidemiology; Epilepsy; Status epilepticus; Treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; TOPIRAMATE; VALPROIC ACID;

APNEA; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTINUOUS INFUSION; DISEASE CLASSIFICATION; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; ELDERLY CARE; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; INCIDENCE; LETHARGY; LOADING DRUG DOSE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; RESPIRATION DEPRESSION; REVIEW; SEIZURE; SOMNOLENCE; SPIKE WAVE; TREATMENT DURATION;

EID: 84872894075     PISSN: 20358385     EISSN: 20358377     Source Type: Journal    
DOI: 10.4081/ni.2012.e17     Document Type: Review

References (62)

1. Rona S, Rosenow F, Arnold S, et al. A semiological classification of status epilepticus. Epileptic Disord 2005;7:5-12.
2. DeToledo JC. Changing presentation of seizures with aging: clinical and etiological factors. Gerontology 1999;45:329-35
3. Willmore LJ. Epilepsy emergencies: the first seizure and status epilepticus. Neurology 1998;51:S34-8.
4. Waterhouse E, Towne A. Seizures in the elderly: nuances in presentation and treatment. Cleve Clin J Med 2005;72Suppl 3:S26-37.
5. Waterhouse EJ, DeLorenzo RJ. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging 2001;18:133-42.
6. Towne AR. Epidemiology and outcomes of status epilepticus in the elderly. Int Rev Neurobiol 2007;81:111-27.
7. ILAE. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22:489-501.
8. Kandula P, Harden C. Management of status epilepticus. In: Schapira AHV. Neurology and clinical neuroscience. Philadelphia: Mosby Inc; 2007. pp. 719-31.
9. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia 1999;40:120-2.
10. Blume WT, Luders HO, Mizrahi E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001;42:1212-8.
11. Lowenstein DH. The management of refractory status epilepticus: an update. Epilepsia 2006;47 Suppl1:35-40.
12. Varelas PN, Mirski MA. Status epilepticus. Curr Neurol Neurosci Rep 2009;9:469-76.
13. Kaplan PW. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 1999;16:341-53.
14. Hesdorffer DC, Logroscino G, Cascino G, et al. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998;50:735-41.
15. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-35.
16. Wu YW, Shek DW, Garcia PA, et al. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002;58:1070-6.
17. Vignatelli L, Tonon C, D'Alessandro R. Incidence and short-term prognosis of status epilepticus in adults in Bologna,Italy. Epilepsia 2003;44:964-8.
18. Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001;42:714-8.
19. Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000;55:693-7.
20. Tejeiro J, Gomez Sereno B. [Status epilepticus]. Rev Neurol 2003;36:661-79. [Article in Spanish].
21. DeLorenzo R. Clinical and epidemiology study of status epilepticus in the elderly. Newton, MA: Butterworth-Heinemann; 1997.
22. Krumholz A. Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16: 314-22.
23. Shneker BF, Fountain NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003;61:1066-73.
24. Korn-Lubetzki I, Steiner-Birmanns B, Galperin I, et al. Nonconvulsive status epilepticus in older people: a diagnostic challenge and a treatable condition. J Am Geriatr Soc 2007;55:1475-6.
25. Forcadas I. [Status epilepticus in the elderly]. Neurologia 1997;12 Suppl 6:46-53. [Article in Spanish].
26. Kaplan PW. Nonconvulsive status epilepticus. Neurology 2003;61:1035-6.
27. Sheth RD, Drazkowski JF, Sirven JI, et al. Protracted ictal confusion in elderly patients. Arch Neurol 2006;63:529-32.
28. Rosenow F, Hamer HM, Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia 2007;48 Suppl8:82-4.
29. Sung CY, Chu NS. Status epilepticus in the elderly: etiology, seizure type and outcome.Acta Neurol Scand 1989;80:51-6.
30. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995;12:316-25.
31. Rumbach L, Sablot D, Berger E, et al. Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology 2000;54:350-4.
32. Tatum WOt, Ross J, Cole AJ. Epileptic pseudodementia. Neurology 1998;50:14725.
33. Velioglu SK, Ozmenoglu M, Boz C, Alioglu Z. Status epilepticus after stroke. Stroke 2001;32:1169-72.
34. De Reuck J, Van Maele G. Status epilepticus in stroke patients. Eur Neurol 2009;62: 171-5.
35. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia 1992;33 Suppl4:S15-25.
36. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
37. Waterhouse EJ, Vaughan JK, Barnes TY, et al. Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res 1998;29:175-83.
38. Litt B, Wityk RJ, Hertz SH, et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998;39: 1194-202.
39. Van Cott AC. Epilepsy and EEG in the elderly. Epilepsia 2002;43 Suppl3:94-102.
40. Rowan AJ, Ramsay RE, Collins JF, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-73.
41. Kellinghaus C, Loddenkemper T, Dinner DS, et al. Seizure semiology in the elderly: a video analysis. Epilepsia 2004;45:263-7.
42. Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology 1992;42:100-4.
43. Lee SI. Nonconvulsive status epilepticus. Ictal confusion in later life. Arch Neurol 1985;42:778-81.
44. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000;54:340-5.
45. Leppik IE, Derivan AT, Homan RW, et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-4.
46. Garzon E. Estado de Mal Epiléptico. J Epilepsy Clin Neurophysiol 2008;14:7-11.
47. Fischer JH, Patel TV, Fischer PA. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet 2003;42:33-58.
48. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. [Neurology International 2012; 4:e17] Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-8.
49. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia 1999;40 Suppl1:S59-63.
50. Pluhar J, Birnbaum, AK, Graves, NM. Valproic acid serum concentrations and daily dose in elderly nursing home residents: effects of age, gender, and concomitant medications. Epilepsia 1999;40:70.
51. Beyenburg S, Bauer J, Reuber M. New drugs for the treatment of epilepsy: a practical approach. Postgrad Med J 2004;80: 581-7.
52. Rossetti AO, Bromfield EB. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol 2005;54:34-8.
53. Beyenburg S, Reuber M, Maraite N. Intravenous levetiracetam for epileptic seizure emergencies in older people. Gerontology 2009;55:27-31.
54. Atefy R, Tettenborn B. Nonconvulsive status epilepticus on treatment with levetiracetam. Epilepsy Behav 2005;6:613-6.
55. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993;43:483-8.
56. Treiman DM, Walton, NY, Collins NF, Point P. Treatment of status epilepticus if first drug fails. Epilepsia 1999;40:243.
57. Lowenstein DH, Aminoff MJ, Simon RP. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology 1988;38:395-400.
58. Yaffe K, Lowenstein DH. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 1993;43:895-900.
59. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994;44:1837-40.
60. Stecker MM, Kramer TH, Raps EC, et al. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998;39:18-26.
61. Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001;42:380-6.
62. Towne AR, Garnett LK, Waterhouse EJ, et al. The use of topiramate in refractory status epilepticus. Neurology 2003;60:332-4.